Melinta Therapeutics(MLNT)

chuminhua2021-03-16 17:53

3月15日，新型抗生素研发公司MelintaTherapeutics宣布美国FDA已批准其Kimyrsa（oritavancin），用于治疗由指定革兰氏阳性微生物的敏感分离株（包括耐甲氧西林金黄色葡萄球菌，MRSA）引起的急性细菌性皮肤和皮肤结构感染（ABSSSI）成人患者。Kimyrsa是一种糖肽类抗生素，1小时单剂输注1200 mg就可提...查看全文

悲剧！又一家开发新型抗生素的上市公司申请破产

医药魔方2019-12-31 09:21

继今年上半年开发抗生素的上市公司Achaogen申请破产之后，另外一家专注开发新型抗生素的上市公司Melinta Therapeutics也在近日按照《美国破产法典》第11章程序申请破产。
Melinta是Cempra制药公司的继承实体。Cempra制药公司位于北卡罗来纳州教堂山市，于2005年11月18日成立，是一家开发抗细菌...查看全文

牛唐2019-10-25 08:03

$Melinta Therapeutics(MLNT)$ 抗生素又上演sell on news的惨剧查看全文

华尔街操盘手_2019-06-19 21:54

$Melinta Therapeutics(MLNT)$ 今天暴涨股 170% $Axalta涂层系统(AXTA)$查看全文

静心成佛2019-05-11 13:49

$Melinta Therapeutics(MLNT)$ 踩雷了，还好只是试探性建仓。查看全文

crystalcacn2019-04-11 04:53

$Melinta Therapeutics(MLNT)$ okey查看全文

用户48783635432019-04-10 11:18

【4月9日医药股盘点】$Histogenics(HSGX)$$PhaseBio制药(PHAS)$ $Melinta Therapeutics(MLNT)$ 细胞疗法公司Histogenics同制药公司Ocugen合并，上涨56%；制药公司PhaseBio Pharmaceuticals上涨17.15%；抗生素开发公司Melinta Therapeutics上涨15.15%等。查看全文网页链接查看全文

无记名人氏2019-04-09 00:04

$Melinta Therapeutics(MLNT)$ 买入查看全文

$Melinta Therapeutics, Inc.(MLNT)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-01-09 AccNo: 0001193125-18-007407 Size: 765 KB 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-09 AccNo: 0001193805-18-000030 Size: 161 KB 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2018-01-09 AccNo: 0001193125-18-007279 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of...

$Melinta Therapeutics, Inc.(MLNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-01-08 AccNo: 0001193125-18-006148 Size: 92 KB 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2018-01-03 AccNo: 0001193125-18-001687 Size: 13 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:/...

$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-12-27 AccNo: 0001193125-17-380114 Size: 20 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ DEF 14A - Other definitive proxy statements Filed: 2017-12-15 AccNo: 0001193125-17-370805 Size: 5 MB 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-12-11 AccNo: 0000315066-17-002930 Size: 9 KB 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ 8-K/A [Amend] - Current report Filed: 2017-12-06 AccNo: 0001193125-17-362842 Size: 17 KBItem 9.01: Financial Statements and Exhibits 网页链接

$Melinta Therapeutics, Inc.(MLNT)$ PRE 14A - Other preliminary proxy statements Filed: 2017-12-05 AccNo: 0001193125-17-361793 Size: 5 MB 网页链接